
Global Biosurgery Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
-
1693
-
Jan 2022
-
185
-
PDF
-
-
Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
-
Global Biosurgery Market Overview:
“The global Biosurgery Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031.”
The report offers insightful and detailed information regarding the various key players operating in the global biosurgery market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global biosurgery market report has been segmented on the basis of product type, application, and region.
Bio-surgery is a surgical technique used to heal wounds with help of maggots. It is also used when a person is infected with bugs which are resistant to antibiotics.
Biosurgery is also known as larva therapy or maggot therapy. Green bottle larvae are most commonly used for these type of surgeries. These maggots are applied on wounds when they are few millimeters in length. Usually the maggots are placed on the wounds for up-to three or four days.
Increasing adoption of bio-surgery in the treatment of wounds especially for diabetic patients, and in the treatment of spinal injuries are key factors driving the growth of the global biosurgery market.
In addition, bio-surgeries are also used to help stop blood flow from damaged vessels, and disinfect wounds which are major factors expected to fuel growth to the global bio-surgery market.
However, high cost of surgery is a key factor restraining the growth of the global bio-surgery market. Additionally, lack of awareness among people, low preference among the general population for bio-surgeries, and government regulations in certain countries are some major factors expected to hamper the growth of the global bio-surgery market over the forecast period.
Moreover, owing to rise in sport and spine related injuries preference to bio-surgery treatment is increasing. This is a major trend evident in the market.
North America is a dominant player in the global biosurgery market and accounts for highest market share in terms of revenue as compared to that of markets in other regions.
This can be attributed to the well-developed healthcare industry, presence of leading medical diagnostics centers, and increasing incidence of neuro and spine injuries in the region.
The market in Europe accounted for second-highest revenue share contribution in the global biosurgery market followed by markets in Asia Pacific and Middle East & Africa respectively. The market in Asia Pacific is projected to have fastest growth in terms of revenue, owing to rising demand for minimally invasive surgeries.
Global Biosurgery Market Segmentation:
Global biosurgery market segmentation by product type:
- Anti-adhesive agent
- Hemostatic agent
Global biosurgery market segmentation by application:
- Orthopedic surgery
- Neuro spine surgery
Global biosurgery market segmentation by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn -
- Atrium Medical Corporation
- Braun Melsungen AG
- Baxter International Inc.
- R. Bard, Inc.
- Cryolife, Inc.
- Hemostasis, LLC
- Johnson & Johnson Services, Inc.
- Sanofi
- Stryker
-
Request for TOC
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!